| Literature DB >> 27829660 |
Jun-Ichi Suzuki1, Hiroki Sato2, Makoto Kaneko2, Asuka Yoshida2, Norio Aoyama2, Shouta Akimoto1, Kouji Wakayama1, Hidetoshi Kumagai1, Yuichi Ikeda3, Hiroshi Akazawa3, Yuichi Izumi2, Mitsuaki Isobe4, Issei Komuro3.
Abstract
There is a deep relationship between cardiovascular disease and periodontitis. It has been reported that myocardial hypertrophy may be affected by periodontitis in clinical settings. Although these clinical observations had some study limitations, they strongly suggest a direct association between severity of periodontitis and left ventricular hypertrophy. However, the detailed mechanisms between myocardial hypertrophy and periodontitis have not yet been elucidated. Recently, we demonstrated that periodontal bacteria infection is closely related to myocardial hypertrophy. In murine transverse aortic constriction models, a periodontal pathogen, Aggregatibacter actinomycetemcomitans markedly enhanced cardiac hypertrophy with matrix metalloproteinase-2 activation, while another pathogen Porphyromonas gingivalis (P.g.) did not accelerate these pathological changes. In the isoproterenol-induced myocardial hypertrophy model, P.g. induced myocardial hypertrophy through Toll-like receptor-2 signaling. From our results and other reports, regulation of chronic inflammation induced by periodontitis may have a key role in the treatment of myocardial hypertrophy. In this article, we review the pathophysiological mechanism between myocardial hypertrophy and periodontitis.Entities:
Mesh:
Year: 2016 PMID: 27829660 DOI: 10.1038/hr.2016.146
Source DB: PubMed Journal: Hypertens Res ISSN: 0916-9636 Impact factor: 3.872